SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437786-18-000026
Filing Date
2018-04-26
Accepted
2018-04-26 10:54:05
Documents
5
Period of Report
2018-06-13
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A def2018proxystatement.htm DEF 14A 704893
2 image0a11.jpg GRAPHIC 19059
3 image3a04.jpg GRAPHIC 10381
4 finalproxycard001.jpg GRAPHIC 124413
5 finalproxycard002.jpg GRAPHIC 107083
  Complete submission text file 0001437786-18-000026.txt   1055323
Mailing Address 601 GATEWAY BOULEVARD SUITE 250 SOUTH SAN FRANCISCO CA 94080
Business Address 1616 EASTLAKE AVENUE E. SUITE 310 SEATTLE WA 98102 (650) 392-8350
IMMUNE DESIGN CORP. (Filer) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36561 | Film No.: 18776926
SIC: 2834 Pharmaceutical Preparations